Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review.
Document Type
Article
Publication Date
2-19-2025
Abstract
PURPOSE OF REVIEW: This review explores the role of artificial intelligence (AI) in cardio-oncology, focusing on its latest application across problems in diagnosis, prognosis, risk stratification, and management of cardiovascular (CV) complications in cancer patients. It also highlights multi-omics analysis, explainable AI, and real-time decision-making, while addressing challenges like data heterogeneity and ethical concerns.
RECENT FINDINGS: AI can advance cardio-oncology by leveraging imaging, electronic health records (EHRs), electrocardiograms (ECG), and multi-omics data for early cardiotoxicity detection, stratification and long-term risk prediction. Novel AI-ECG models and imaging techniques improve diagnostic accuracy, while multi-omics analysis identifies biomarkers for personalized treatment. However, significant barriers, including data heterogeneity, lack of transparency, and regulatory challenges, hinder widespread adoption. AI significantly enhances early detection and intervention in cardio-oncology. Future efforts should address the impact of AI technologies on clinical outcomes, and ethical challenges, to enable broader clinical adoption and improve patient care.
Publication Title
Current cardiology reports
Volume
27
Issue
1
First Page
56
Last Page
56
Recommended Citation
Guha, A., Shah, V., Nahle, T., Singh, S., Kunhiraman, H., Shehnaz, F., Nain, P., Makram, O., Mahmoudi, M., Al-Kindi, S., Madabhushi, A., Shiradkar, R., & Daoud, H. (2025). Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review.. Current cardiology reports, 27 (1), 56-56. https://doi.org/https://doi.org/10.1007/s11886-025-02215-w